clofibrate has been researched along with Glycogen Storage Disease Type I in 1 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greene, HL | 1 |
| Slonim, AE | 1 |
| O'Neill, JA | 1 |
| Burr, IM | 1 |
1 other study available for clofibrate and Glycogen Storage Disease Type I
| Article | Year |
|---|---|
Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.
Topics: Adolescent; Aspartate Aminotransferases; Blood Glucose; Child; Cholesterol; Clofibrate; Eating; Ente | 1976 |